251 related articles for article (PubMed ID: 33575781)
1. Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review.
Mazhar F; Battini V; Pozzi M; Invernizzi E; Mosini G; Gringeri M; Capuano A; Scavone C; Radice S; Clementi E; Carnovale C
Int J Neuropsychopharmacol; 2021 Jul; 24(6):477-489. PubMed ID: 33575781
[TBL] [Abstract][Full Text] [Related]
2. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C
CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
[TBL] [Abstract][Full Text] [Related]
3. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
4. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
[TBL] [Abstract][Full Text] [Related]
5. Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study.
Fusaroli M; Giunchi V; Battini V; Gringeri M; Rimondini R; Menchetti M; Radice S; Pozzi M; Nobile M; Clementi E; De Ponti F; Carnovale C; Raschi E; Poluzzi E
Psychiatry Clin Neurosci; 2023 Mar; 77(3):160-167. PubMed ID: 36436204
[TBL] [Abstract][Full Text] [Related]
6. Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS).
Stamoula E; Stamatellos VP; Vavilis T; Dardalas I; Papazisis G
Expert Opin Drug Saf; 2024 Feb; 23(2):239-245. PubMed ID: 37589503
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system.
Burk BG; DiGiacomo T; Polancich S; Pruett BS; Sivaraman S; Birur B
Acta Psychiatr Scand; 2023 Jul; 148(1):32-46. PubMed ID: 37194481
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
9. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
10. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.
Mannesse CK; van Puijenbroek EP; Jansen PA; van Marum RJ; Souverein PC; Egberts TC
Drug Saf; 2010 Jul; 33(7):569-78. PubMed ID: 20553058
[TBL] [Abstract][Full Text] [Related]
11. Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System.
Fusaroli M; Simonsen A; Borrie SA; Low DM; Parola A; Raschi E; Poluzzi E; Fusaroli R
J Speech Lang Hear Res; 2023 Sep; 66(9):3242-3259. PubMed ID: 37524118
[TBL] [Abstract][Full Text] [Related]
12. Paliperidone-Associated Hyponatremia: Report of a Fatal Case With Analysis of Cases Reported in the Literature and to the US Food and Drug Administration Adverse Event Reporting System.
Mazhar F; Carnovale C; Haider N; Ahmed R; Taha M
J Clin Psychopharmacol; 2020; 40(2):202-205. PubMed ID: 32068565
[No Abstract] [Full Text] [Related]
13. Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.
Meulendijks D; Mannesse CK; Jansen PA; van Marum RJ; Egberts TC
Drug Saf; 2010 Feb; 33(2):101-14. PubMed ID: 20082537
[TBL] [Abstract][Full Text] [Related]
14. A positron emission tomography occupancy study of brexpiprazole at dopamine D
Girgis RR; Forbes A; Abi-Dargham A; Slifstein M
Neuropsychopharmacology; 2020 Apr; 45(5):786-792. PubMed ID: 31847007
[TBL] [Abstract][Full Text] [Related]
15. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
17. The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: A case/non-case study using VigiBase.
Aguiar JP; Alves da Costa F; Egberts T; Leufkens H; Souverein P
Eur Neuropsychopharmacol; 2020 Jun; 35():30-38. PubMed ID: 32409260
[TBL] [Abstract][Full Text] [Related]
18. [Antidepressive agents and hyponatremia: A literature review and a case/non-case study in the French Pharmacovigilance database].
Rochoy M; Zakhem-Stachera C; Béné J; Berkhout C; Gautier S;
Therapie; 2018 Oct; 73(5):389-398. PubMed ID: 29773358
[TBL] [Abstract][Full Text] [Related]
19. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
[TBL] [Abstract][Full Text] [Related]
20. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
Fusaroli M; Raschi E; Giunchi V; Menchetti M; Rimondini Giorgini R; De Ponti F; Poluzzi E
Int J Neuropsychopharmacol; 2022 Sep; 25(9):727-736. PubMed ID: 35639870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
